The city of Gainesville, Florida, currently has 16 active clinical trials seeking participants for Diabetes research studies.
Lactobacillus Johnsonii in Children and Adolescents With T1D
NCT03961854
Recruiting
While genetics demonstrated a major risk factor for the development of type 1 diabetes (T1D), microbiota dysbiosis has been suggested as an elicitor in immunological tolerance and of beta cell autoimmunity. The probiotic Lactobacillus johnsonii N6.2 may prevent or restore the gut flora and show systemic impacts and adaptive immunity in the T1D population thereby preserving beta cell function.
Gender:
All
Ages:
Between 8 years and 18 years
Trial Updated:
08/07/2023
Locations: UF Clinical Research Center, Gainesville, Florida
Conditions: Type 1 Diabetes (T1D)
Register for Updates
Obesity and Uric Acid Stones Study
NCT04621929
Recruiting
The investigator proposes an 18 month, feasibility pilot study, randomizing obese and diabetic individuals with pure uric acid nephrolithiasis (UAN) or mixed calcium oxalate (CO) UAN to either phentermine/topiramate or a pragmatic control group who will remain on their standard medication regimen (citrate salts, allopurinol, diet, etc.).
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
06/09/2023
Locations: University of Florida, Gainesville, Florida
Conditions: Obesity, Uric Acid Stones, Type 2 Diabetes Mellitus in Obese, Pre-Diabetes
Register for Updates
Continuous Glucose Monitoring for Hyperglycemia in Critically Ill Patients
NCT05442853
Recruiting
The investigators intend to conduct a single-center, prospective, randomized comparative trial of patients admitted to the intensive care unit (ICU) who received continuous glucose monitoring (CGM) vs point of care (POC) glucose monitoring. The study will examine relevant outcomes for patients in the ICU with diabetes mellitus and/or hyperglycemia. The primary outcome of the study will be the proportion of time in target range (blood glucose 70-180 mg/dL).
Gender:
All
Ages:
Between 18 years and 89 years
Trial Updated:
03/13/2023
Locations: North Florida/South Georgia Veterans Health System, Gainesville, Florida
Conditions: Hyperglycemia, Hypoglycemia, Critical Illness, Diabetes Mellitus
Register for Updates
Continuous Monitoring and Control of Hypoglycemia
NCT03340831
Recruiting
Evaluate safety of non-adjunctive CGM use in CGM naive participants.
Gender:
All
Ages:
2 years and above
Trial Updated:
09/17/2021
Locations: University of Florida Pediatric Endocrinology, Gainesville, Florida
Conditions: Diabetes
Register for Updates